Australians with ADHD could face drug shortages for rest of year, TGA says

TruthLens AI Suggested Headline:

"Australia Faces ADHD Medication Shortages Due to Manufacturing Issues"

View Raw Article Source (External Link)
Raw Article Publish Date:
AI Analysis Average Score: 8.9
These scores (0-10 scale) are generated by Truthlens AI's analysis, assessing the article's objectivity, accuracy, and transparency. Higher scores indicate better alignment with journalistic standards. Hover over chart points for metric details.

TruthLens AI Summary

Australia is currently facing a shortage of methylphenidate, a common medication used to treat attention deficit hyperactivity disorder (ADHD), as reported by the Therapeutic Goods Administration (TGA). This medication, available under brand names such as Ritalin, Ritalin LA, and Concerta, is experiencing supply issues due to manufacturing difficulties. The TGA has advised patients to consult with their doctors and pharmacists to explore alternative options for managing their ADHD. While this shortage has been an ongoing concern for several months, experts like Professor Dave Coghill from the University of Melbourne are urging individuals with ADHD to remain calm, emphasizing that not all ADHD medications are currently in short supply. He pointed out that methylphenidate is just one of four types of medications utilized for ADHD treatment, and the shortages vary by brand and dosage, making it essential for patients to seek guidance from healthcare professionals regarding their treatment plans.

Professor Coghill explained the implications of these medication shortages, noting that ADHD affects approximately one in twenty Australians, leading to challenges in attention, concentration, focus, planning, and impulsivity. He stressed that ADHD medications are not only beneficial for improving focus and concentration but also play a crucial role in helping individuals think before they act, thus enhancing overall safety and productivity in their lives. The current shortages are attributed to a surge in global demand for ADHD medications and regulatory restrictions on the production of key ingredients by the US Drug Enforcement Agency. In response to the ongoing situation, the TGA has established a medicine shortage action group, comprising health professionals and peak body representatives, to address and manage the challenges posed by these drug shortages effectively.

TruthLens AI Analysis

You need to be a member to generate the AI analysis for this article.

Log In to Generate Analysis

Not a member yet? Register for free.

Unanalyzed Article Content

People with attention deficit hyperactivity disorder are being advised to contact their doctor as Australia’s drug regulator warned a common medication used to treat the condition may be in short supply for the rest of the year.

Methylphenidate – known by its brand names as Ritalin, Ritalin LA and Concerta – is in short supply in Australia due to manufacturing issues, according to a notice from the Therapeutic Goods Administration on Wednesday, which advised people to speak to their pharmacist to help source their prescription.

ADHD drug shortageshave been an ongoing problem in Australia for a number of months. But Prof Dave Coghill, Chair of Development Mental Health at the University of Melbourne, is warning people who live with ADHD not to panic, saying not all forms of ADHD medication are currently experiencing a shortage.

He said methylphenidate is only one of four medications used to treat ADHD, and even within that class of drug, there is not a complete shortage but a shortage of some brands at some doses.

Sign up for Guardian Australia’s breaking news email

“The problem we have is the ones that are in shortage are changing constantly so it’s very difficult to predict from one week to the next which medications are going to be available,” Coghill said, adding people who live with ADHD should speak with their doctor to work out a good alternative medication.

ADHD is a neurodevelopmental disorder that affects how the brain develops, processes and handles information. About one in 20 Australians have it.

“People who live with ADHD have problems in three main areas, which is difficulty with attention/concentration, focus and planning,” Coghill said.

“They often have problems with overactivity and restlessness … and they also often have impulsivity or impulsiveness.”

Coghill said medication shortages can be challenging.

“We’ve now got good evidence to show that the ADHD medications not only help you concentrate and focus but help you to stop and think before you act,” Coghill said.

Sign up toBreaking News Australia

Get the most important news as it breaks

after newsletter promotion

“So they don’t just make people feel better, but actually they help people live safer, more productive lives, and ADHD medications are really a key to helping people manage those symptoms.”

A massive increase in demand globally for ADHD drugs as well as restrictions placed on the manufacture of one of the core ingredients by the US Drug Enforcement Agency has led to the shortages, Coghill said.

The TGA has convened a medicine shortage action group with health professional and peak body groups to help manage the ongoing shortages..

Back to Home
Source: The Guardian